ofloxacin has been researched along with ascorbic acid in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Asif, M; Husain, A; Iqbal, MA; Iram, F; Khan, SA | 1 |
| Jiang, X; Liu, XH; Shi, J; Tang, W; Wang, S; Wu, C; Xu, Y; Zha, L; Zhang, J; Zhang, Z; Zuo, J | 1 |
| Dobias, J; Ebringer, L; Krajcvoic, J; Krizková, L; Lahitová, N; Polónyi, J | 1 |
| Bishayi, B; Dey, S | 1 |
2 review(s) available for ofloxacin and ascorbic acid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Insights into the chemistry and therapeutic potential of furanones: A versatile pharmacophore.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antifungal Agents; Antineoplastic Agents; Antiviral Agents; Humans; Molecular Structure | 2019 |
4 other study(ies) available for ofloxacin and ascorbic acid
| Article | Year |
|---|---|
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Novel cannabidiol-carbamate hybrids as selective BuChE inhibitors: Docking-based fragment reassembly for the development of potential therapeutic agents against Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Binding Sites; Blood-Brain Barrier; Butyrylcholinesterase; Cannabidiol; Carbamates; Cell Line, Tumor; Cell Survival; Cholinesterase Inhibitors; Drug Design; Humans; Kinetics; Maze Learning; Mice; Mice, Inbred ICR; Molecular Docking Simulation; Neuroprotective Agents; Structure-Activity Relationship | 2021 |
Antimutagens reduce ofloxacin-induced bleaching in Euglena gracilis.
Topics: Animals; Anti-Infective Agents; Antimutagenic Agents; Ascorbic Acid; Butylated Hydroxyanisole; Butylated Hydroxytoluene; Dose-Response Relationship, Drug; Euglena gracilis; Ofloxacin; Sodium Selenite | 1996 |
Killing of S. aureus in murine peritoneal macrophages by Ascorbic acid along with antibiotics Chloramphenicol or Ofloxacin: Correlation with inflammation.
Topics: Animals; Anti-Bacterial Agents; Antioxidants; Ascorbic Acid; Chloramphenicol; Cyclooxygenase 2; Cytokines; Drug Therapy, Combination; Hydrogen Peroxide; Inflammation; Macrophages, Peritoneal; Male; Methicillin-Resistant Staphylococcus aureus; Mice; Nitric Oxide; Ofloxacin; Phagocytosis; Staphylococcal Infections; Superoxides; Toll-Like Receptor 2 | 2018 |